ESCRS - Preloaded intraocular lens injection system ;
ESCRS - Preloaded intraocular lens injection system ;

Preloaded intraocular lens injection system

Latest news from the industry in October 2016 EuroTimes

Preloaded intraocular lens injection system
Colin Kerr
Colin Kerr
Published: Friday, September 30, 2016
rayner_2658 Rayner launched the RayOne®, their fully preloaded intraocular lens (IOL) injection system, at the XXXIV Congress of the ESCRS in Copenhagen. Designed from the outset to work together, the RayOne lens and injector makes micro-incision cataract surgery (MICS) quicker and easier with the smallest-tipped preloaded IOL system currently on the market, said CEO Tim Clover. Ease of use and safety were RayOne design priorities, Clover added. Patented “Lock & Roll” technology rolls the lens tightly before pushing it forward in the fully enclosed cartridge, enabling smooth, consistent injection with minimum force and maximum control. The 1.65mm nozzle is parallel-sided for minimal stretch, supporting wound-in lens injection through sub-2.2mm incisions. www.rayner.com FDA APPROVAL The Medical Technology Business Group of Zeiss has announced FDA approval of the VisuMax® small incision lenticule extraction (SMILE) procedure. “I thank the surgeons and clinics who have paved the way for Zeiss to be able to bring this new innovative technology to refractive practices throughout the US,” said James V Mazzo, Global President of Ophthalmic Devices, and President and CEO of the company’s US organisation. www.zeiss.com NEW CEO appointed Avedro, Inc. has announced the appointment of Reza Zadno, medical device entrepreneur, as the company’s CEO. “We are very pleased to have Reza join Avedro’s senior executive team as CEO,” said Gil Kliman, Managing Director at InterWest Partners, and a member of the Avedro Board of Directors. “His entrepreneurial skills and proven leadership will help assure the successful commercialisation of 
our recently FDA-approved crosslinking device and drugs in the US, and speed our clinical development 
of PiXL, a first-in-category, non-surgical procedure for the correction of myopia.” www.avedro.com
Tags: IOLs, SMILE
Latest Articles
Glaucoma Treatment Under Pressure

New techniques and technologies add to surgeons’ difficult decisions

Read more...

Outside the Box, Inside the Pipeline

Researchers are tackling glaucoma diagnosis and treatment from all sides.

Read more...

The EHDS Is Ready for the Green Light

If proposal is approved, Europe could see better access to, and exchange and use of, health data.

Read more...

ESCRS to Release Guidelines for Cataract and Refractive Surgery

Comprehensive approach to the safest and most effective modern surgery.

Read more...

Barry Fellowship Opens Up ‘Whole New Field of Thought’

The 2022 recipient combines theoretical and practical to learn new treatments.

Read more...

Digitalising the OR—Experience and Perspectives

Benefits include saving time and improving outcomes.

Read more...

ESCRS Heritage Programme

Visionaries past and present.

Read more...

Dynamic Measures Needed for Quality of Vision

Functional visual acuity testing and straylight metering may better reflect real-world conditions.

Read more...

What Is Stopping Digital OR Adoption?

Ophthalmologists know the benefits—now it’s time to construct the right plan.

Read more...

Time to Move Beyond Monofocal IOLs?

European surgeons appear hesitant to first offer other presbyopia-correcting options to patients.

Read more...

;